Zoë MacDonald advises public and private companies on mergers and acquisitions and strategic transactions in domestic and cross-border matters. She has experience across a range of industries, including technology, artificial intelligence, financial technology, life sciences, and health care.
Most recently, Zoë assisted with Bora Pharmaceuticals' $122.5 million acquisition of the GMP manufacturing operations of MacroGenics (Nasdaq: MGNX).
Outside of her transactional work, Zoë is committed to an active pro bono practice through the Firm's Border Project, where she provides on-the-ground legal support to asylum clients at detention facilities in Laredo, Texas.
Zoë is the author of "Defending Children’s Data Privacy: Strategies for the 21st Century," 76 UC Law SF L.J. 589 (2025).
担当案件
- University of California College of the Law, San Francisco (J.D. 2025; Business Law Certificate; Thurston Society; UC Law SF Honor Society; Executive Notes Editor, UC Law Journal; Startup Legal Garage Student Associate); San Diego State University (B.S. summa cum laude 2021)
- California